Evidence for interaction between v-Mos and a p34cdc2 isoform, p35cdk

W Bai1, B Singh, Y Yang

  • 1Department of Molecular Pathology, University of Texas M.D. Anderson Cancer Center, Houston 77030.

Oncogene
|September 1, 1992
PubMed

Insights

The viral Mos protein (v-Mos) interacts with a novel cell cycle protein, p35cdk, in transformed cells. This interaction suggests v-Mos may disrupt cell cycle control, contributing to neoplastic transformation.

Area of Science:

  • Molecular Biology
  • Cell Cycle Regulation
  • Oncogenesis

Background:

  • The cellular Mos protein (c-Mos) is a kinase crucial for meiotic maturation and cell cycle arrest.
  • The viral Mos protein (v-Mos) is implicated in neoplastic transformation.
  • Understanding v-Mos's interaction with cellular components is key to its oncogenic mechanism.

Purpose of the Study:

  • To identify cellular proteins interacting with v-Mos.
  • To investigate the role of v-Mos in cell cycle dysregulation.
  • To explore potential v-Mos-mediated oncogenic pathways.

Main Methods:

  • Gel filtration chromatography of NIH3T3 cell extracts.
  • Immunoprecipitation using antibodies against p34cdc2.
  • Binding assays with p13suc1-conjugated beads.

Main Results:

  • A 500-kDa complex containing v-Mos and a p34cdc2 isoform (p35cdk) was identified.
  • This complex exhibited histone H1 kinase activity.
  • Co-immunoprecipitation and p13suc1 binding confirmed the v-Mos-p35cdk interaction.

Conclusions:

  • v-Mos forms a complex with p35cdk, a novel cdc2 isoform.
  • This interaction suggests a regulatory role for v-Mos in cell cycle control.
  • The v-Mos-p35cdk interaction may be a mechanism for v-Mos-induced neoplastic transformation.

Related Concept Videos

Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...